Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Potkin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Neuropharmacology|January 1, 1986
Eye movements in remitting and non-remitting schizophreniaT Kojima, E Matsushima, H Moriya, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1988
Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophreniaC W Heh, J Herrera, E DeMet, et al.
Brain Research|August 8, 1997
Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brainsS W Tang, D M Helmeste, H Fang, et al.
Schizophrenia Research|March 1, 1993
Olfactory memory in unmedicated schizophrenicsJ Wu, M S Buchsbaum, K Moy, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1990
Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomographyM S Buchsbaum, K H Nuechterlein, R J Haier, et al.
Clinical Neuropharmacology|January 1, 1992
PET studies of drug interaction with brain regional glucose metabolismM S Buchsbaum, S Potkin, B Siegel, et al.
Science (New York, N.Y.)|October 26, 1979
A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in manJ E Kleinman, S Potkin, A Rogol, et al.
Archives of General Psychiatry|June 1, 1977
Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosineH A Nasrallah, E F Donnelly, L B Bigelow, et al.
Neuropeptides|February 1, 1985
Lower CSF level of dynorphin(1-8) immunoreactivity in schizophrenic patientsA Z Zhang, G Z Zhou, G F Xi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Neuropharmacology|January 1, 1986
Eye movements in remitting and non-remitting schizophreniaT Kojima, E Matsushima, H Moriya, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1988
Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophreniaC W Heh, J Herrera, E DeMet, et al.
Brain Research|August 8, 1997
Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brainsS W Tang, D M Helmeste, H Fang, et al.
Schizophrenia Research|March 1, 1993
Olfactory memory in unmedicated schizophrenicsJ Wu, M S Buchsbaum, K Moy, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1990
Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomographyM S Buchsbaum, K H Nuechterlein, R J Haier, et al.
Clinical Neuropharmacology|January 1, 1992
PET studies of drug interaction with brain regional glucose metabolismM S Buchsbaum, S Potkin, B Siegel, et al.
Science (New York, N.Y.)|October 26, 1979
A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in manJ E Kleinman, S Potkin, A Rogol, et al.
Archives of General Psychiatry|June 1, 1977
Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosineH A Nasrallah, E F Donnelly, L B Bigelow, et al.
Neuropeptides|February 1, 1985
Lower CSF level of dynorphin(1-8) immunoreactivity in schizophrenic patientsA Z Zhang, G Z Zhou, G F Xi, et al.
Pageof 2